Wall Street Analysts See a 91.92% Upside in NovoCure (NVCR): Can the Stock Really Move This High?

• click to rate

  Posted by Two Blokes 9 hours ago - Filed in Stock - 1 view
  
  The average of price targets set by Wall Street analysts indicates a potential upside of 91.9% in NovoCure (NVCR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.